The regulation of N-methyl- d -aspartate receptors by Src kinase

FEBS Journal

Volumn 279, Issue 1, 2012, Pages 20-28

  Groveman, Bradley R ^a   Feng, Shuang ^a,b   Fang, Xiao Qian ^a   Pflueger, Melissa ^a   Lin, Shuang Xiu ^a   Bienkiewicz, Ewa A ^a   Yu, Xianmin ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

NMDA receptors; protein unfolding; PTP and Csk; Src family kinases; the SH2 and SH3 domains

Indexed keywords

C TERMINAL PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE ALPHA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME REGULATION; ENZYME STABILITY; ENZYME SUBSTRATE COMPLEX; LONG TERM POTENTIATION; MOLECULAR INTERACTION; NONHUMAN; POSTSYNAPTIC DENSITY; PRIORITY JOURNAL; PROTEIN STABILITY; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 83655167387     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08413.x     Document Type: Review

References (106)

1. Beacham D, Ahn M, Catterall WA, &, Scheuer T, (2007) Sites and molecular mechanisms of modulation of Na(v)1. 2 channels by Fyn tyrosine kinase. J Neurosci 27, 11543-11551. (Pubitemid 350006890)
2. Ahn M, Beacham D, Westenbroek RE, Scheuer T, &, Catterall WA, (2007) Regulation of Na(v)1. 2 channels by brain-derived neurotrophic factor, TrkB, and associated Fyn kinase. J Neurosci 27, 11533-11542. (Pubitemid 350006889)
3. Tong Q, &, Stockand JD, (2005) Receptor tyrosine kinases mediate epithelial Na(+) channel inhibition by epidermal growth factor. Am J Physiol Renal Physiol 288, F150-F161. (Pubitemid 40038687)
4. Li Y, Langlais P, Gamper N, Liu F, &, Shapiro MS, (2004) Dual phosphorylations underlie modulation of unitary KCNQ K(+) channels by Src tyrosine kinase. J Biol Chem 279, 45399-45407. (Pubitemid 39491523)
5. Ling S, Woronuk G, Sy L, Lev S, &, Braun AP, (2000) Enhanced activity of a large conductance, calcium-sensitive K+ channel in the presence of Src tyrosine kinase. J Biol Chem 275, 30683-30689.
6. Sobko A, Peretz A, &, Attali B, (1998) Constitutive activation of delayed-rectifier potassium channels by a src family tyrosine kinase in Schwann cells. EMBO J 17, 4723-4734. (Pubitemid 28377172)
7. Shimohama S, (2009) Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. Biol Pharm Bull 32, 332-336.
8. Lee G, (2005) Tau and src family tyrosine kinases. Biochim Biophys Acta 1739, 323-330. (Pubitemid 40018548)
9. Rouer E, (2010) [Neuronal isoforms of Src, Fyn and Lck tyrosine kinases: a specific role for p56lckN in neuron protection]. C R Biol 333, 1-10.
10. Sperber BR, Boyle-Walsh EA, Engleka MJ, Gadue P, Peterson AC, Stein PL, Scherer SS, &, McMorris FA, (2001) A unique role for Fyn in CNS myelination. J Neurosci 21, 2039-2047. (Pubitemid 32221386)
11. Kramer-Albers EM, &, White R, (2011) From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. Cell Mol Life Sci 68, 2003-2012.
12. Nelson TJ, Sun MK, Hongpaisan J, &, Alkon DL, (2008) Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur J Pharmacol 585, 76-87.
13. Grosshans DR, &, Browning MD, (2001) Protein kinase C activation induces tyrosine phosphorylation of the NR2A and NR2B subunits of the NMDA receptor. J Neurochem 76, 737-744. (Pubitemid 32126073)
14. Grosshans DR, Clayton DA, Coultrap SJ, &, Browning MD, (2001) LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1. Nat Neurosci 5, 27-33. (Pubitemid 34038779)
15. Lu WY, Xiong ZG, Lei S, Orser BA, Dudek E, Browning MD, &, MacDonald JF, (1999) G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci 2, 331-338. (Pubitemid 30491275)
16. Meissirel C, Ruiz dA, Knevels E, Coulon C, Chounlamountri N, Segura I, de Rossi P, Vinckier S, Anthonis K, Deleglise B, et al. (2011) VEGF modulates NMDA receptors activity in cerebellar granule cells through Src-family kinases before synapse formation. Proc Natl Acad Sci USA 108, 13782-13787.
17. Florian C, Vecsey CG, Halassa MM, Haydon PG, &, Abel T, (2011) Astrocyte-derived adenosine and A1 receptor activity contribute to sleep loss-induced deficits in hippocampal synaptic plasticity and memory in mice. J Neurosci 31, 6956-6962.
18. Halassa MM, Florian C, Fellin T, Munoz JR, Lee SY, Abel T, Haydon PG, &, Frank MG, (2009) Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 61, 213-219.
19. Jones BE, (2009) Glia, adenosine, and sleep. Neuron 61, 156-157.
20. Deng Q, Terunuma M, Fellin T, Moss SJ, &, Haydon PG, (2011) Astrocytic activation of A1 receptors regulates the surface expression of NMDA receptors through a Src kinase dependent pathway. Glia 59, 1084-1093.
21. Yagi T, (1999) Molecular mechanisms of Fyn-tyrosine kinase for regulating mammalian behaviors and ethanol sensitivity. Biochem Pharmacol 57, 845-850. (Pubitemid 29128619)
22. Brandon NJ, Delmas P, Hill J, Smart TG, &, Moss SJ, (2001) Constitutive tyrosine phosphorylation of the GABA(A) receptor gamma 2 subunit in rat brain. Neuropharmacology 41, 745-752. (Pubitemid 32972192)
23. A receptor function by tyrosine phosphorylation of beta subunits. J Neurosci 17, 5062-5069. (Pubitemid 27263819)
24. Boxall AR, (2000) GABAergic mIPSCs in rat cerebellar Purkinje cells are modulated by TrkB and mGluR1-mediated stimulation of Src. J Physiol 524, 677-684. (Pubitemid 30303617)
25. Jurd R, Tretter V, Walker J, Brandon NJ, &, Moss SJ, (2010) Fyn kinase contributes to tyrosine phosphorylation of the GABA(A) receptor gamma2 subunit. Mol Cell Neurosci 44, 129-134.
26. Zhang F, Li C, Wang R, Han D, Zhang QG, Zhou C, Yu HM, &, Zhang GY, (2007) Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion. Neuroscience 150, 938-949. (Pubitemid 350235792)
27. Goldman-Rakic PS, Castner SA, Svensson TH, Siever LJ, &, Williams GV, (2004) Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) 174, 3-16. (Pubitemid 38925085)
28. Castner SA, &, Williams GV, (2007) Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex. Brain Cogn 63, 94-122.
29. Hu JL, Liu G, Li YC, Gao WJ, &, Huang YQ, (2010) Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons. Mol Brain 3, 20.
30. Napolitano M, Picconi B, Centonze D, Bernardi G, Calabresi P, &, Gulino A, (2006) L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases. Neurosci Lett 398, 211-214. (Pubitemid 43673714)
31. Gibb SL, Jeanblanc J, Barak S, Yowell QV, Yaka R, &, Ron D, (2011) Lyn kinase regulates mesolimbic dopamine release: implication for alcohol reward. J Neurosci 31, 2180-2187.
32. Salter MW, &, Kalia LV, (2004) Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci 5, 317-328. (Pubitemid 38478658)
33. Kotecha SA, &, MacDonald JF, (2003) Signaling molecules and receptor transduction cascades that regulate NMDA receptor-mediated synaptic transmission. Int Rev Neurobiol 54, 51-106.
34. Kalia LV, &, Salter MW, (2003) Interactions between Src family protein tyrosine kinases and PSD-95. Neuropharmacology 45, 720-728. (Pubitemid 38340358)
35. Tezuka T, Umemori H, Akiyama T, Nakanishi S, &, Yamamoto T, (1999) PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D- aspartate receptor subunit NR2A. Proc Natl Acad Sci USA 96, 435-440. (Pubitemid 29061226)
36. Fanning AS, &, Anderson JM, (1999) PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest 103, 767-772. (Pubitemid 29152621)
37. Gomperts SN, (1996) Clustering membrane proteins: it's all coming together with the PSD-95/SAP90 protein family. Cell 84, 659-662.
38. Kornau HC, Schenker LT, Kennedy MB, &, Seeburg PH, (1995) Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269, 1737-1740.
39. Sheng M, &, Sala C, (2001) Pdz domains and the organization of supramolecular complexes. Annu Rev Neurosci 24, 1-29. (Pubitemid 32695221)
40. Kalia LV, Pitcher GM, Pelkey KA, &, Salter MW, (2006) PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex. EMBO J 25, 4971-4982. (Pubitemid 44607041)
41. Gingrich JR, Pelkey KA, Fam SR, Huang Y, Petralia RS, Wenthold RJ, &, Salter MW, (2004) Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2. Proc Natl Acad Sci USA 101, 6237-6242. (Pubitemid 38520558)
42. Groveman BR, Xue S, Marin V, Xu J, Ali MK, Bienkiewicz EA, &, Yu XM, (2011) Roles of the SH2 and SH3 domains in the regulation of neuronal Src kinase functions. FEBS J 278, 643-653.
43. Brown MT, &, Cooper JA, (1996) Regulation, substrates and functions of src. Biochim Biophys Acta 1287, 121-149. (Pubitemid 26189191)
44. Ponniah S, Wang DZ, Lim KL, &, Pallen CJ, (1999) Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Curr Biol 9, 535-538. (Pubitemid 29257109)
45. Su J, Muranjan M, &, Sap J, (1999) Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Curr Biol 9, 505-511. (Pubitemid 29257105)
46. Zheng XM, Resnick RJ, &, Shalloway D, (2000) A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. EMBO J 19, 964-978. (Pubitemid 30119822)
47. Thomas SM, &, Brugge JS, (1997) Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13, 513-609. (Pubitemid 28034534)
48. den Hertog J, Pals CE, Peppelenbosch MP, Tertoolen LG, de Laat SW, &, Kruijer W, (1993) Receptor protein tyrosine phosphatase alpha activates pp60c-src and is involved in neuronal differentiation. EMBO J 12, 3789-3798. (Pubitemid 23282755)
49. Lei G, Xue S, Chery N, Liu Q, Xu J, Kwan CL, Fu Y, Lu YM, Liu M, Harder KH, et al. (2002) Gain control of N-methyl-D-aspartate receptor activity by receptor-like protein tyrosine phopshatase alpha. EMBO J 21, 2977-2989. (Pubitemid 34670382)
50. Petrone A, Battaglia F, Wang C, Dusa A, Su J, Zagzag D, Bianchi R, Casaccia-Bonnefil P, Arancio O, &, Sap J, (2003) Receptor protein tyrosine phosphatase alpha is essential for hippocampal neuronal migration and long-term potentiation. EMBO J 22, 4121-4131. (Pubitemid 37021741)
51. Skelton MR, Ponniah S, Wang DZ, Doetschman T, Vorhees CV, &, Pallen CJ, (2003) Protein tyrosine phosphatase alpha (PTP alpha) knockout mice show deficits in Morris water maze learning, decreased locomotor activity, and decreases in anxiety. Brain Res 984, 1-10. (Pubitemid 36976789)
52. Okada M, &, Nakagawa H, (1989) A protein tyrosine kinase involved in regulation of pp60c-src function. J Biol Chem 264, 20886-20893. (Pubitemid 20017891)
53. Okada M, Nada S, Yamanashi Y, Yamamoto T, &, Nakagawa H, (1991) CSK: a protein-tyrosine kinase involved in regulation of src family kinases. J Biol Chem 266, 24249-24252. (Pubitemid 21908933)
54. Imamoto A, &, Soriano P, (1993) Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73, 1117-1124. (Pubitemid 23180486)
55. Nada S, Yagi T, Takeda H, Tokunaga T, Nakagawa H, Ikawa Y, Okada M, &, Aizawa S, (1993) Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell 73, 1125-1135. (Pubitemid 23180487)
56. Dey N, Howell BW, De PK, &, Durden DL, (2005) CSK negatively regulates nerve growth factor induced neural differentiation and augments AKT kinase activity. Exp Cell Res 307, 1-14. (Pubitemid 40732729)
57. Colognato H, Ramachandrappa S, Olsen IM, &, ffrench-Constant C, (2004) Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol 167, 365-375. (Pubitemid 39435078)
58. Nada S, Shima T, Yanai H, Husi H, Grant SG, Okada M, &, Akiyama T, (2003) Identification of PSD-93 as a substrate for the Src family tyrosine kinase Fyn. J Biol Chem 278, 47610-47621. (Pubitemid 37523205)
59. Xu J, Weerapura M, Ali MK, Jackson MF, Li H, Lei G, Xue S, Kwan CL, Manolson MF, Yang K, et al. (2008) Control of excitatory synaptic transmission by C-terminal Src kinase. J Biol Chem 283, 17503-17514.
60. Khanna S, Roy S, Park HA, &, Sen CK, (2007) Regulation of c-Src activity in glutamate-induced neurodegeneration. J Biol Chem 282, 23482-23490. (Pubitemid 47311965)
61. D'Arco M, Giniatullin R, Leone V, Carloni P, Birsa N, Nair A, Nistri A, &, Fabbretti E, (2009) The C-terminal Src inhibitory kinase (Csk)-mediated tyrosine phosphorylation is a novel molecular mechanism to limit P2X3 receptor function in mouse sensory neurons. J Biol Chem 284, 21393-21401.
62. Kawabuchi M, Satomi Y, Takao T, Shimonishi Y, Nada S, Nagai K, Tarakhovsky A, &, Okada M, (2000) Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 404, 999-1003. (Pubitemid 30243594)
63. Shima T, Nada S, &, Okada M, (2003) Transmembrane phosphoprotein Cbp senses cell adhesion signaling mediated by Src family kinase in lipid rafts. Proc Natl Acad Sci USA 100, 14897-14902. (Pubitemid 37517988)
64. Fang XQ, Xu J, Feng S, Groveman BR, Lin SX, &, Yu XM, (2011) The NMDA receptor NR1 subunit is critically involved in the regulation of NMDA receptor activity by C-terminal Src kinase (Csk). Neurochem Res 36, 319-326.
65. Lau LF, &, Huganir RL, (1995) Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits. J Biol Chem 270, 20036-20041.
66. Yang M, &, Leonard JP, (2001) Identification of mouse NMDA receptor subunit NR2A C-terminal tyrosine sites phosphorylated by coexpression with v-Src. J Neurochem 77, 580-588. (Pubitemid 32298752)
67. Xu W, Harrison SC, &, Eck MJ, (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602. (Pubitemid 27087566)
68. Ingley E, (2008) Src family kinases: regulation of their activities, levels and identification of new pathways. Biochim Biophys Acta 1784, 56-65.
69. Roskoski R Jr, (2005) Src kinase regulation by phosphorylation and dephosphorylation. Biochem Biophys Res Commun 331, 1-14. (Pubitemid 40545134)
70. Boggon TJ, &, Eck MJ, (2004) Structure and regulation of Src family kinases. Oncogene 23, 7918-7927. (Pubitemid 39468851)
71. Sicheri F, &, Kuriyan J, (1997) Structures of Src-family tyrosine kinases. Curr Opin Struct Biol 7, 777-785. (Pubitemid 28025103)
72. Howell BW, &, Cooper JA, (1994) Csk suppression of Src involves movement of Csk to sites of Src activity. Mol Cell Biol 14, 5402-5411. (Pubitemid 24235968)
73. Gonfloni S, Weijland A, Kretzschmar J, &, Superti-Furga G, (2000) Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src. Nat Struct Biol 7, 281-286. (Pubitemid 30194450)
74. Bradshaw JM, (2010) The Src, Syk, and Tec family kinases: distinct types of molecular switches. Cell Signal 22, 1175-1184.
75. Jaenicke R, (1993) What does protein refolding in vitro tell us about protein folding in the cell? Philos Trans R Soc Lond [Biol] 339, 287-295.
76. Matouschek A, (2003) Protein unfolding-an important process in vivo? Curr Opin Struct Biol 13, 98-109. (Pubitemid 36170261)
77. Forman JR, &, Clarke J, (2007) Mechanical unfolding of proteins: insights into biology, structure and folding. Curr Opin Struct Biol 17, 58-66. (Pubitemid 46240817)
78. Harris KF, Shoji I, Cooper EM, Kumar S, Oda H, &, Howley PM, (1999) Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc Natl Acad Sci USA 96, 13738-13743.
79. Kmiecik TE, &, Shalloway D, (1987) Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49, 65-73.
80. Falsone SF, Leptihn S, Osterauer A, Haslbeck M, &, Buchner J, (2004) Oncogenic mutations reduce the stability of SRC kinase. J Mol Biol 344, 281-291. (Pubitemid 39422388)
81. Marin V, Groveman BR, Qiao H, Xu J, Ali MK, Fang XQ, Lin SX, Rizkallah R, Hurt MH, Bienkiewicz EA, et al. (2010) Characterization of neuronal Src kinase purified from a bacterial expression system. Protein Expr Purif 74, 289-297.
82. Parsons SJ, &, Parsons JT, (2004) Src family kinases, key regulators of signal transduction. Oncogene 23, 7906-7909. (Pubitemid 39468849)
83. Zhang HJ, Sheng XR, Pan XM, &, Zhou JM, (1997) Activation of adenylate kinase by denaturants is due to the increasing conformational flexibility at its active sites. Biochem Biophys Res Commun 238, 382-386.
84. Shoichet BK, Baase WA, Kuroki R, &, Matthews BW, (1995) A relationship between protein stability and protein function. Proc Natl Acad Sci USA 92, 452-456.
85. Meiering EM, Serrano L, &, Fersht AR, (1992) Effect of active site residues in barnase on activity and stability. J Mol Biol 225, 585-589.
86. Schreiber G, Buckle AM, &, Fersht AR, (1994) Stability and function: two constraints in the evolution of barstar and other proteins. Structure 2, 945-951.
87. Hibler DW, Stolowich NJ, Reynolds MA, Gerlt JA, Wilde JA, &, Bolton PH, (1987) Site-directed mutants of staphylococcal nuclease. Detection and localization by 1H NMR spectroscopy of conformational changes accompanying substitutions for glutamic acid-43. Biochemistry 26, 6278-6286.
88. Poole LB, Loveys DA, Hale SP, Gerlt JA, Stanczyk SM, &, Bolton PH, (1991) Deletion of the omega-loop in the active site of staphylococcal nuclease. 1. Effect on catalysis and stability. Biochemistry 30, 3621-3627.
89. Gleason FK, (1992) Mutation of conserved residues in Escherichia coli thioredoxin: effects on stability and function. Protein Sci 1, 609-616. (Pubitemid 23009196)
90. Beadle BM, &, Shoichet BK, (2002) Structural bases of stability-function tradeoffs in enzymes. J Mol Biol 321, 285-296.
91. Thomas VL, McReynolds AC, &, Shoichet BK, (2010) Structural bases for stability-function tradeoffs in antibiotic resistance. J Mol Biol 396, 47-59.
92. Patwardhan P, &, Resh MD, (2010) Myristoylation and membrane binding regulate c-Src stability and kinase activity. Mol Cell Biol 30, 4094-4107.
93. Stone JC, Atkinson T, Smith M, &, Pawson T, (1984) Identification of functional regions in the transforming protein of Fujinami sarcoma virus by in-phase insertion mutagenesis. Cell 37, 549-558. (Pubitemid 14079049)
94. Sadowski I, Stone JC, &, Pawson T, (1986) A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol Cell Biol 6, 4396-4408. (Pubitemid 17217381)
95. Filippakopoulos P, Muller S, &, Knapp S, (2009) SH2 domains: modulators of nonreceptor tyrosine kinase activity. Curr Opin Struct Biol 19, 643-649.
96. Filippakopoulos P, Kofler M, Hantschel O, Gish GD, Grebien F, Salah E, Neudecker P, Kay LE, Turk BE, Superti-Furga G, et al. (2008) Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation. Cell 134, 793-803.
97. Rous P, (1911) A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13, 397-411.
98. Martin GS, (2004) The road to Src. Oncogene 23, 7910-7917. (Pubitemid 39468850)
99. Aleshin A, &, Finn RS, (2010) SRC: a century of science brought to the clinic. Neoplasia 12, 599-607.
100. Lowell CA, Niwa M, Soriano P, &, Varmus HE, (1996) Deficiency of the Hck and Src tyrosine kinases results in extreme levels of extramedullary hematopoiesis. Blood 87, 1780-1792. (Pubitemid 26068894)
101. Mayer EL, &, Krop IE, (2010) Advances in targeting SRC in the treatment of breast cancer and other solid malignancies. Clin Cancer Res 16, 3526-3532.
102. Cohen P, (2002) Protein kinases-the major drug targets of the twenty-first century? Nat Rev Drug Discov 1, 309-315. (Pubitemid 37361447)
103. Saad F, &, Lipton A, (2010) SRC kinase inhibition: targeting bone metastases and tumor growth in prostate and breast cancer. Cancer Treat Rev 36, 177-184.
104. Liu XJ, Gingrich JR, Vargas-Caballero M, Dong YN, Sengar A, Beggs S, Wang SH, Ding HK, Frankland PW, &, Salter MW, (2008) Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex. Nat Med 14, 1325-1332.
105. Bielefeld EC, Hynes S, Pryznosch D, Liu J, Coleman JK, &, Henderson D, (2005) A comparison of the protective effects of systemic administration of a pro-glutathione drug and a Src-PTK inhibitor against noise-induced hearing loss. Noise Health 7, 24-30. (Pubitemid 46951049)
106. Harris KC, Hu B, Hangauer D, &, Henderson D, (2005) Prevention of noise-induced hearing loss with Src-PTK inhibitors. Hear Res 208, 14-25. (Pubitemid 41430381)